Der Internist
The most recent articles from:
Internist (Berl)
-
Randomized Controlled Trial Multicenter Study Comparative Study
[Janus kinase inhibitor baricitinib for rheumatoid arthritis : Randomized, double-blind, placebo- and active-controlled, phase 3 study evaluating the efficacy and safety of baricitinib in patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to methotrexate therapy (RA-BEAM)].
-
Randomized Controlled Trial
[Effects of glycemic index on cardiovascular risk factors: The OmniCarb randomized clinical trial].
-
Randomized Controlled Trial Multicenter Study
[Endovascular treatment for acute ischemic stroke : Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands (MR CLEAN)].